Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2026-01-22 @ 3:34 AM
Study NCT ID:
NCT06808568
Status:
AVAILABLE
Last Update Posted:
2025-02-05
First Post:
2025-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program (EAP) STIMULAN VG
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D003668', 'term': 'Pressure Ulcer'}], 'ancestors': [{'id': 'D012883', 'term': 'Skin Ulcer'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'EXPANDED_ACCESS', 'expandedAccessTypes': {'individual': True}, 'nPtrsToThisExpAccNctId': 2}, 'statusModule': {'overallStatus': 'AVAILABLE', 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-01', 'lastUpdateSubmitDate': '2025-01-29', 'studyFirstSubmitDate': '2025-01-29', 'studyFirstSubmitQcDate': '2025-01-29', 'lastUpdatePostDateStruct': {'date': '2025-02-05', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2025-02-05', 'type': 'ACTUAL'}}, 'conditionsModule': {'conditions': ['Stage IV Pressure Ulcer', 'Diabetic Foot Osteomyelitis']}, 'descriptionModule': {'briefSummary': 'Individual (single) patient expanded access may be considered.', 'detailedDescription': 'Patients facing serious or life-threatening illnesses who have exhausted currently available treatment options and are ineligible or unable to participate in a clinical trial may decide to explore therapeutic use of investigational drugs with their healthcare providers.\n\nUnder these circumstances, single-patient access can be requested from a licensed treating physician on behalf of the patient.\n\nPlease contact expandedaccess@biocomposites.com for more information.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'eligibilityCriteria': 'Inclusion Criteria:\n\n\\-\n\nExclusion Criteria:\n\n\\-'}, 'identificationModule': {'nctId': 'NCT06808568', 'acronym': 'EAPSTIMVG', 'briefTitle': 'Expanded Access Program (EAP) STIMULAN VG', 'organization': {'class': 'INDUSTRY', 'fullName': 'Biocomposites Ltd'}, 'officialTitle': 'Expanded Access Program (EAP) STIMULAN VG', 'orgStudyIdInfo': {'id': 'EAPSTIMVG'}}, 'armsInterventionsModule': {'interventions': [{'name': 'STIMULAN VG', 'type': 'COMBINATION_PRODUCT'}]}, 'contactsLocationsModule': {'centralContacts': [{'name': 'Biocomposites Expanded Access Team', 'role': 'CONTACT', 'email': 'expandedaccess@biocomposites.com', 'phone': '+44 (0) 1782 338 580'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Biocomposites Ltd', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}